Changing Life Sciences Value Chain CommunityLooking Forward Post 2016 Political Elections Alan S. LouieTue, 15 Nov 2016 13:45:58 -0500 Stars are Aligned for Operational Excellence in Life Science R&D in 2016<div><p>The decision to externalize non-core competencies has strongly and irreversibly impacted the life science industry, and especially life science R&amp;D.  External discovery research collaborations are the norm and clinical development is primarily being performed by external CROs in place of internal resources.  These changes have required…</p></div>Dr. Alan S. LouieWed, 06 Jan 2016 14:51:03 -0500 signaling the Tipping Point from Infrastructure to Solutions at BioIT World<div><p>With attendance continuing to grow (2100+ attendees) and an audience composition heavily tilted towards scientific versus IT staff, the BioIT World conference remains a valuable meeting venue focused on effective information technology best practices intended specifically to advance progress in the life sciences.  Examples of the transition to…</p></div>Dr. Alan S. LouieFri, 01 May 2015 14:28:59 -0400 ResearchKit, a New and Powerful Tool to Better Engage the Life Science Patient Ecosystem<div><p>In increasing real time detailed patient medical data availability, ResearchKit opens up a whole new source of patient insights that should enable life science and healthcare researchers to accelerate disease research, improve patient care, and accelerate clinical trials.  Recent FDA guidance on informed consent is also expected to contribute to…</p></div>Dr. Alan S. LouieFri, 20 Mar 2015 11:02:23 -0400 – The Year the Life Sciences Actively Moved towards Knowledge-based Best Practices<div><p>A number of technological innovations will help us to make the transition forward, slowed only by mankind's inherent resistance to change.  While I've described many of these innovations in detail in a number of previous writings, it is also clear that vendors supporting the industry have also seen the vision and are actively incorporating these…</p></div>Dr. Alan S. LouieFri, 16 Jan 2015 12:11:27 -0500 the Upcoming Life Science Data Security Scarlet Letter<div><p>While effective data security used to entail battening down the firewalls and hiding behind a company's datacenter, the increasingly externalized ecosystem, ease of transferring large amounts of data on a thumbdrive, disgruntled staffer, or potential to leave a laptop in a cab are actively on the minds of those charged with maintaining data…</p></div>Dr. Alan S. LouieWed, 03 Dec 2014 13:14:51 -0500 the Internet of Things in the Life Sciences<div><p>Leveraging technological advances from remote healthcare monitoring in the healthcare provider space, it is becoming increasingly possible and practical to actively measure a patient's medical condition in real time and share this information with their caregivers and doctors.  In all cases, it will be important to have the explicit permission of…</p></div>Dr. Alan S. LouieThu, 30 Oct 2014 10:54:37 -0400 Change in Regulatory Information Management (RIM): Technology Can Help to Make Compliance Transparent and Boost Organizational Efficiency and Effectiveness<div><p>Effective content management systems can also contain significant embedded intelligence by translating industry best practices into automated workflows that can be used to automatically identify omissions and discrepancies, highlight important deadlines, assess whether a submission is complete (and identify missing documents, if any), and enable…</p></div>Dr. Alan S. LouieWed, 17 Sep 2014 20:00:48 -0400 Science Supply Chain Investment Looks to Rebound<div><p>Based on data from our recently conducted 2014 Life Science Manufacturing and Supply Chain IT Benchmark Guide, IDC Health insights expects investment to pick up and return to growth levels closer to historical averages, exceeding 4%, and breaking $7 billion in total IT investment industry wide during 2014.</p> <p>Life science companies are exploring…</p></div>Eric NewmarkMon, 08 Sep 2014 09:45:17 -0400 are delivering more value than ever before, both to life science R&D and consumers<div><p>As patient engagement grows as a focus of new drug development, particularly in the areas of clinical trial recruitment and participation, smartphones are expected to contribute more routinely as the primary interface between trial sponsors, PIs, and patients. Advances in life science-based technologies are shrinking traditional diagnostics…</p></div>Dr. Alan S. LouieThu, 24 Jul 2014 15:29:11 -0400